Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Isocarboxazide has been used as long-term treatment for a selected group of 20 depressive patients, of whom some 90% (17/19) were non-responders to treatment with tricyclic antidepressants. At the follow-up the median duration of illness was 162 months, and the median duration of treatment was 42 mo...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1111/j.1600-0447.1980.tb00634.x
データ提供：米国国立医学図書館（NLM）
Isocarboxazide: A Potential Oasis in the Desert of Treatment-Resistant Depression
Depression, a debilitating mental health condition, can be challenging to treat, with some individuals failing to respond to conventional therapies. This research explores the long-term efficacy of isocarboxazide, a monoamine oxidase inhibitor (MAOI), in treating a group of 20 patients with treatment-resistant depression. The study reports that a significant majority of patients responded better to isocarboxazide than to other antidepressant medications, suggesting its potential as a valuable treatment option for individuals with resistant depression.
Isocarboxazide: A Potential Solution for Treatment-Resistant Depression
This research offers a glimmer of hope for individuals struggling with treatment-resistant depression, a condition that can be particularly challenging to manage. The study highlights the potential of isocarboxazide as a viable treatment option for this group of patients, offering a promising alternative to conventional therapies. The findings underscore the importance of considering a broader range of treatment options for individuals with resistant depression.
Navigating the Desert of Depression: Exploring Treatment Options
The journey through depression can be a long and arduous one, particularly for individuals who do not respond to conventional therapies. This research provides valuable insights into the potential of isocarboxazide as a treatment option for resistant depression, highlighting the importance of exploring a range of therapeutic approaches to ensure optimal outcomes for all patients. It underscores the need for personalized treatment plans and ongoing research to develop more effective treatments for this debilitating condition.
Dr. Camel's Conclusion
Treatment-resistant depression can feel like a vast and unforgiving desert, with few oases of hope. This research offers a promising alternative in the form of isocarboxazide, highlighting its potential to provide relief for individuals struggling with this challenging condition. It underscores the importance of exploring a range of treatment options and pursuing personalized care to ensure optimal outcomes for all patients navigating the difficult terrain of depression.
Date :
- Date Completed 1981-05-26
- Date Revised 2019-08-15
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.